VEPALIMOMAB
UNII 0M19J59UH4

Substance Identification & Data

This profile provides standardized clinical and technical data for Vepalimomab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 0M19J59UH4.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 195158-85-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
0M19J59UH4
CAS Registry Number
195158-85-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
VEPALIMOMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
7757
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Vepalimomab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VEPALIMOMAB

Common Names & Synonyms

VEPALIMOMAB [INN]

Brand / Trade Names

VAPANTIX

Systematic Nomenclature

IMMUNOGLOBULIN M (MOUSE MONOCLONAL 1B2 -CHAIN ANTI-HUMAN VASCULAR ADHESION PROTEIN VAP-1), DISULFIDE WITH MOUSE MONOCLONAL 1B2 LIGHT CHAIN, DIMER